GVI
Green Valley Investors Portfolio holdings
AUM $1.76B
1-Year Return
5.68%
This Quarter Return
-9.16%
1 Year Return
+5.68%
3 Year Return
+59.49%
5 Year Return
+81.18%
10 Year Return
–
AUM
$4.66B
AUM Growth
-$532M
(-10%)
Cap. Flow
-$69.4M
Cap. Flow
% of AUM
-1.49%
Top 10 Holdings %
Top 10 Hldgs %
66.13%
Holding
29
New
2
Increased
3
Reduced
2
Closed
2
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
+$109M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$40.5M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
+$34M |
| 4 |
Walt Disney
DIS
|
+$30.7M |
| 5 |
PX
Praxair Inc
PX
|
+$20.4M |
Top Sells
| 1 |
Comcast
CMCSA
|
+$174M |
| 2 |
AbbVie
ABBV
|
+$67.2M |
| 3 |
Sysco
SYY
|
+$48.7M |
| 4 |
Henry Schein
HSIC
|
+$13.3M |
Sector Composition
| 1 | Healthcare | 58.31% |
| 2 | Consumer Discretionary | 13.19% |
| 3 | Materials | 12.04% |
| 4 | Consumer Staples | 7.88% |
| 5 | Communication Services | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESRX
1
DELISTED
Express Scripts Holding Company
ESRX
| $733M | 15.71% |
9,050,000
| – | – |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $498M | 10.67% |
4,600,000
| – | – |
|
3
Johnson & Johnson
JNJ
$425B
| $338M | 7.26% |
3,625,000
| – | – |
|
4
Gilead Sciences
GILD
$138B
| $295M | 6.32% |
3,000,000
| – | – |
|
5
LKQ Corp
LKQ
$8.11B
| $221M | 4.74% |
7,800,000
| – | – |
|
6
TJX Companies
TJX
$155B
| $214M | 4.59% |
6,000,000
| – | – |
|
7
Stryker
SYK
$144B
| $207M | 4.44% |
2,200,000
| – | – |
|
|
8
Walt Disney
DIS
$207B
| $204M | 4.38% |
2,000,000
+300,000
| +18% | +$30.7M |
|
9
Walmart
WMT
$825B
| $195M | 4.17% |
9,000,000
| – | – |
|
10
Marriott International Class A Common Stock
MAR
$72.7B
| $180M | 3.85% |
2,634,371
| – | – |
|
|
TFCFA
11
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $162M | 3.47% |
6,000,000
+1,500,000
| +33% | +$40.5M |
|
12
Thermo Fisher Scientific
TMO
$179B
| $147M | 3.15% |
1,200,000
| – | – |
|
13
International Flavors & Fragrances
IFF
$16.5B
| $145M | 3.1% |
1,400,000
| – | – |
|
14
Bausch Health
BHC
$2.51B
| $143M | 3.06% |
800,000
| – | – |
|
|
PX
15
DELISTED
Praxair Inc
PX
| $122M | 2.62% |
1,200,000
+200,000
| +20% | +$20.4M |
|
16
Abbott
ABT
$229B
| $121M | 2.59% |
3,000,000
| – | – |
|
|
AGN
17
DELISTED
Allergan plc
AGN
| $109M | 2.33% |
+400,000
| New | +$109M |
|
|
POT
18
DELISTED
Potash Corp Of Saskatchewan
POT
| $108M | 2.31% |
5,250,000
| – | – |
|
19
Procter & Gamble
PG
$370B
| $99.3M | 2.13% |
1,380,000
| – | – |
|
|
20
Henry Schein
HSIC
$8.34B
| $78.4M | 1.68% |
1,505,367
-255,000
| -14% | -$13.3M |
|
21
Air Products & Chemicals
APD
$63.4B
| $76.5M | 1.64% |
648,600
| – | – |
|
22
DuPont de Nemours
DD
$32.3B
| $67.8M | 1.45% |
793,067
| – | – |
|
23
Vertex Pharmaceuticals
VRTX
$101B
| $52.1M | 1.12% |
500,000
| – | – |
|
24
Colgate-Palmolive
CL
$65.9B
| $44.4M | 0.95% |
700,000
| – | – |
|
|
MON
25
DELISTED
Monsanto Co
MON
| $42.7M | 0.91% |
500,000
| – | – |
|